France-based biotech firm Global Bioenergies announced on June 3 that it has officially begun the process of finding a buyer through a “pre-pack sale” as part of an ongoing conciliation procedure. Interested parties have until July 9 to submit their purchase offers.
The company, active for over a decade, developed a proprietary technology to produce biobased isobutene—a versatile compound used in the energy, materials, and cosmetics sectors. In mid-2024, Global Bioenergies revealed that it had adapted its process to produce e-SAF (electro-based sustainable aviation fuel) from biobased feedstocks. The method involves converting carbon dioxide and hydrogen into e-SAF using acetic acid as a key input.
By October 2024, the company had announced a strategic pivot to focus exclusively on e-SAF production. The shift came after it was unable to secure sufficient investment for a planned facility aimed at supplying the cosmetics industry.
With the transition to sustainable aviation fuel now at the core of its business strategy, Global Bioenergies is seeking new ownership to carry forward its next phase of development.
